Davis v. Saidro

District Court, S.D. California·Decided January 26, 2021·No. 3:18-cv-02838·Unknown

Opinion

RONNELL DAVIS, Case No.: 18-CV-2838-LAB(WVG)

Plaintiff, REPORT AND v. RECOMMENDATION ON DEFENDANTS’ MOTION FOR SAIDRO et al., SUMMARY JUDGMENT Defendants. [Doc. No. 12.] Plaintiff, a California state prisoner proceeding pro se, brought this civil rights action under 42 U.S.C. § 1983. Pending before the Court is Defendants’ motion for summary judgment on the Complaint’s sole claim for violation of the Eighth Amendment. As explained below, this Court RECOMMENDS the motion be GRANTED, that judgment be entered in Defendants’ favor, and that the case be closed. / / / / / / / / / / / / / / / A. Defendants’ Statement of Facts1 On October 2, 2013, Plaintiff was diagnosed with deep vein thrombosis (DVT) in his lower right leg. DVT is the formation of a blood clot in a deep vein. DVT may cause symptoms such as pain and swelling in the affected area, and it also carries the risk of pulmonary embolism (PE), whereby the clot detaches and becomes lodged in an artery that supplies blood to the lungs. PE may be fatal. Five days after the DVT diagnosis, Plaintiff was diagnosed with and treated for PE. Since that time, Plaintiff has been on warfarin therapy to reduce the risk of recurring DVT or PE. The goal of warfarin therapy is to decrease the tendency of the patient’s blood to clot, thereby helping to prevent the formation of clots that could lead to DVT or PE. However, care must be taken that the patient’s blood does not become too slow to clot. Otherwise, the patient would be at risk for bleeding. Therefore, the blood’s ability to clot is checked regularly and the dosage of warfarin adjusted accordingly. Prothrombin time (PT) is a measure of the time it takes a clot to form. PT is usually expressed as a ratio to a control sample, the International Normalization Ratio (INR). The average person not on warfarin would have an INR of 1.0. The longer it takes the blood to clot, the higher the INR. The target (therapeutic) range for a patient on warfarin therapy is generally between 2.0 and 3.0. If the level is lower (subtherapeutic), the patient is at an increased risk of clotting and an embolism; if the level is higher (supratherapeutic), the patient is at an increased risk of bleeding. 1 As of this writing, Plaintiff has not filed an opposition to the MSJ despite two extensions of the deadline to do so. (See Doc. Nos. 16, 20.) When the most recent deadline expired on January 19, 2021 (Doc. No. 20), Plaintiff filed neither an opposition nor a request for extension of time as he had filed twice previously. (See Doc. Nos. 15, 19.) Because Plaintiff did not file an opposition to the MSJ, Defendants’ version of facts stands as the only set of Under guidelines issued by the California Correctional Health Care Services, treating physicians are to consider placing a hold on warfarin therapy for any patient whose INR exceeds 4.0. As long as the patient shows no signs of bleeding, physicians may increase the frequency of INR testing and resume warfarin therapy once the INR returns to the therapeutic range. However, if a patient shows signs of serious bleeding, health care providers are advised to withhold warfarin and transfer the patient to a higher level of care. In May 2015, Defendant Dr. Saidro became Plaintiff’s primary care physician at the Richard J. Donovan Correctional Facility (“Donovan” or RJD”). She had primary responsibility for Plaintiff’s health care, including managing his warfarin therapy in conjunction with the anticoagulation clinic at RJD. Dr. Dulatre is a staff pharmacist at Donovan. Since 2015, he has been the manager of the RJD anticoagulation clinic. He manages the anticoagulation medications of inmates by regular appointments, medical record review, and collaboration with other medical providers at Donovan to optimize patients’ drug therapy. Dr. Dulatre is responsible for determining the appropriate dosages of anticoagulants, including warfarin, based on his regular monitoring of his patients’ INR levels. On March 1, 2016, a blood test showed that Plaintiff had an INR of 4.1. Dr. Dulatre received an automated alert that Plaintiff’s INR was excessively high. He consequently ordered a one-day hold of Plaintiff’s warfarin in an effort to return his INR to the therapeutic range. He scheduled Plaintiff for a follow-up appointment on March 8, 2016 and a blood draw on March 9, 2016 to recheck Plaintiff’s INR. However, Plaintiff refused to go to the March 8 appointment and failed to go to the March 9 lab appointment. Dr. Dulatre rescheduled the blood draw for March 11. Plaintiff also failed to show for that appointment. Dr. Dulatre became concerned that it was dangerous to continue Plaintiff on warfarin, since Plaintiff’s refusals of blood draws made it impossible to determine whether the high March 1 INR level had returned to the therapeutic range. After Plaintiff failed to show for his rescheduled blood draw on March 11, Dr. Dulatre called Dr. Saidro and expressed his concerns. Dr. Saidro had Plaintiff summoned to the clinic, where a nurse explained to Plaintiff the reasons he needed to have his blood drawn. Plaintiff again refused a blood draw and refused to sign a Refusal of Medical Treatment form. After the nurse reported to Dr. Saidro that Plaintiff again refused a blood draw, Dr. Saidro ordered a stop to Plaintiff’s warfarin. Plaintiff’s warfarin was stopped that day.2 Dr. Saidro planned to restart Plaintiff’s warfarin once his INR could be verified as no longer excessively high. Plaintiff then prepared a Form 7362 Request for Medical Treatment that he dated March 11, 2016, but which was not received until March 12 and not reviewed until March 13. In it, Plaintiff claimed he was experiencing bloody stool and bruising on his thighs. Both are symptoms of bleeding and are signs that Plaintiff’s blood was taking too long to clot. Plaintiff was seen in the clinic on March 13 because these symptoms required urgent care. A nurse evaluated Plaintiff and noted rapid heartbeat and rapid breathing. She consulted Dr. Bates, the on-call physician in the clinic at the time. Dr. Bates ordered Plaintiff to be taken to the hospital to rule out pulmonary embolism. Medical records show that Plaintiff was first taken to Sharp Chula Vista hospital. X- rays and a CT scan of the chest were both unremarkable and found both of Plaintiff’s lungs were clear. Plaintiff was then transferred to Tri-City Hospital for further care. The admitting physician noted that Plaintiff reported maroon stool the day before, but that was not verified. Plaintiff also reported lower chest/upper abdomen pain. The physician further noted that “[i]t is unclear if there is really much to do,” that he “will hold off any anticoagulants for now” as a result of Plaintiff’s report of maroon stool and that Plaintiff “has obviously ruled out for a PE and his presentation is not consistent with a pulmonary embolism either.” Further tests, including an ultrasound on March 14 and a stress test on March 15 were also unremarkable. Plaintiff was discharged on March 15, 2016. The discharge

Free access — add to your briefcase to read the full text and ask questions with AI

Davis v. Saidro, (S.D. Cal. 2021).

Davis v. Saidro (Davis v. Saidro) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Diebold, Inc.
369 U.S. 654 (Supreme Court, 1962)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Whitley v. Albers
475 U.S. 312 (Supreme Court, 1986)
Malley v. Briggs
475 U.S. 335 (Supreme Court, 1986)
Anderson v. Creighton
483 U.S. 635 (Supreme Court, 1987)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Barbara P. Hutchinson v. United States of America
838 F.2d 390 (Ninth Circuit, 1988)
Taylor v. List
880 F.2d 1040 (Ninth Circuit, 1989)
Eric Sanchez v. Duane R. Vild
891 F.2d 240 (Ninth Circuit, 1989)
John C. McGuckin v. Dr. Smith John C. Medlen, Dr.
974 F.2d 1050 (Ninth Circuit, 1992)
Jackson v. City Of Bremerton
268 F.3d 646 (Ninth Circuit, 2001)
Gibson v. County of Washoe, Nevada
290 F.3d 1175 (Ninth Circuit, 2002)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
John Snow v. E.K. McDaniel
681 F.3d 978 (Ninth Circuit, 2012)